BC
ZSAN

Broadfin Capital’s Zosano Pharma Corporation ZSAN Stock Holding History

Broadfin Capital’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-531
Closed -$1.47M – 98
2015
Q3 		$1.47M Sell
531
-162
-23% -$909K 0.08% 86
2015
Q2 		$3.52M Hold
693
– – 0.19% 82
2015
Q1 		$4.9M Buy
+693
New +$5.2M 0.38% 63

Other funds holding ZSAN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Broadfin Capital's ZSAN Position: Q4 2015 in Review

Broadfin Capital sold out of Zosano Pharma Corporation (ZSAN) in Q4 2015, closing a stake of 531 shares — an estimated $1.47M sold.

Broadfin Capital first reported a position in ZSAN in Q1 2015 and held it in 3 quarters. The position peaked at $4.9M in Q1 2015. 13 funds tracked by Wall St. Rank hold ZSAN as of Q4 2015.

  • Broadfin Capital reported no remaining Zosano Pharma Corporation position as of Q4 2015 after selling out during the quarter.
  • Broadfin Capital sold 531 Zosano Pharma Corporation shares in Q4 2015, an estimated $1.47M.
  • Broadfin Capital first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 3 quarters.
  • Broadfin Capital's Zosano Pharma Corporation position peaked at $4.9M in Q1 2015.
  • 13 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2015.

Based on Broadfin Capital's 13F filing for Q4 2015, filed 16 Feb 2016.